StockDriftsStockDriftsPrestige Biopharma (950210) has 3 disclosed insider purchases and 0 disclosed disposals on record, filed by 1 distinct insiders. Together those filings cover ₩73M ($51K) in reported transaction value. The earliest filing StockDrifts holds for Prestige Biopharma is dated 2024-09-27; the most recent is 2026-07-02. Across these filings the average return since disclosure is -3.74%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-08-28 | BUY | Market Buy | 고상석 Go Sang-seok | - | 27 | ₩6,430 | +1.4% | ₩174K ($121) |
| 2026-08-27 | BUY | Market Buy | 고상석 Go Sang-seok | - | 1.6K | ₩6,250 | +4.3% | ₩10M ($7K) |
| 2026-08-26 | BUY | Market Buy | 고상석 Go Sang-seok | - | 1.6K | ₩6,260 | +4.2% | ₩10M ($7K) |
| 2026-08-25 | BUY | Market Buy | 고상석 Go Sang-seok | - | 1.6K | ₩6,100 | +6.9% | ₩10M ($7K) |
| 2026-08-14 | BUY | Market Buy | 고상석 Go Sang-seok | - | 1.4K | - | - | - |
| 2026-08-13 | BUY | Market Buy | 고상석 Go Sang-seok | - | 960 | - | - | - |
| 2026-08-12 | BUY | Market Buy | 고상석 Go Sang-seok | - | 1.7K | ₩6,890 | +0.0% | ₩12M ($8K) |
| 2026-08-10 | BUY | Market Buy | 고상석 Go Sang-seok | - | 260 | ₩6,600 | +4.4% | ₩2M ($1K) |
| 2026-08-07 | BUY | Market Buy | 박소연 Soyeon Park | Chairman | 1.6K | ₩6,600 | -0.6% | ₩11M ($8K) |
| 2026-08-06 | BUY | Market Buy | 박소연 Soyeon Park | Chairman | 2.2K | ₩6,610 | -0.8% | ₩15M ($10K) |
| 2026-08-05 | BUY | Market Buy | 박소연 Soyeon Park | Chairman | 3.0K | ₩6,500 | +0.9% | ₩20M ($14K) |
| 2026-08-04 | BUY | Market Buy | 박소연 Soyeon Park | Chairman | 3.5K | ₩6,500 | +0.9% | ₩23M ($16K) |
| 2026-07-31 | BUY | Market Buy | 박소연 Soyeon Park | Chairman | 4.4K | ₩6,400 | -0.9% | ₩28M ($19K) |
| 2026-07-30 | BUY | Market Buy | 박소연 Soyeon Park | Chairman | 4.1K | ₩5,720 | +10.8% | ₩23M ($16K) |
| 2026-07-29 | BUY | Market Buy | 박소연 Soyeon Park | Chairman | 5.5K | ₩5,550 | +14.2% | ₩31M ($21K) |
| 2026-07-28 | BUY | Market Buy | 박소연 Soyeon Park | Chairman | 3.9K | ₩5,550 | +14.2% | ₩22M ($15K) |
| 2026-07-28 | BUY | Market Buy | 박소연 Soyeon Park | CEO | 3.9K | ₩5,550 | +15.3% | ₩22M ($15K) |
| 2026-07-27 | BUY | 장외매수 | 박소연 Soyeon Park | CEO | 8.6K | ₩5,610 | +14.1% | ₩48M ($34K) |
| 2026-07-27 | BUY | Market Buy | 박소연 Soyeon Park | Chairman | 3.4K | ₩5,610 | +13.0% | ₩19M ($13K) |
| 2026-07-27 | BUY | 장외매수 | 박소연 Soyeon Park | Chairman | 8.6K | ₩5,610 | +13.0% | ₩48M ($34K) |
| 2026-07-27 | BUY | Market Buy | 박소연 Soyeon Park | CEO | 3.4K | ₩5,610 | +14.1% | ₩19M ($13K) |
| 2026-07-24 | BUY | Market Buy | 박소연 Soyeon Park | CEO | 2.4K | ₩5,250 | +21.9% | ₩13M ($9K) |
| 2026-07-24 | BUY | Market Buy | 박소연 Soyeon Park | Chairman | 2.4K | ₩5,250 | +20.8% | ₩13M ($9K) |
| 2026-07-02 | BUY | Market Buy | 김 마이클 진우 Kim Michael Jinwoo | vice president | 2.0K | ₩6,430 | -11.7% | ₩13M ($9K) |
| 2026-07-02 | BUY | Market Buy | 김 마이클 진우 Kim Michael Jinwoo | vice president | 400 | ₩6,430 | -0.5% | ₩3M ($2K) |
| 2026-06-26 | BUY | Market Buy | 김 마이클 진우 Kim Michael Jinwoo | vice president | 2.9K | ₩5,910 | +2.4% | ₩17M ($12K) |
| 2026-06-26 | BUY | Market Buy | 김 마이클 진우 Kim Michael Jinwoo | vice president | 580 | ₩5,910 | +8.3% | ₩3M ($2K) |
| 2026-06-25 | BUY | Market Buy | 김 마이클 진우 Kim Michael Jinwoo | vice president | 7.0K | ₩6,170 | -1.9% | ₩43M ($30K) |
| 2026-06-25 | BUY | Market Buy | 김 마이클 진우 Kim Michael Jinwoo | vice president | 1.4K | ₩6,170 | +3.7% | ₩9M ($6K) |
| 2025-02-10 | BUY | 시간외매매 | 옥타바펀드리미티드 Octava Fund Limited | - | 250.0K | ₩15,000 | -23.0% | ₩3.8B ($2.6M) |
| 2024-09-27 | BUY | 신규선임 | TAN TING YONG | Other non-executive directors | 6.0K | ₩13,980 | -17.4% | ₩84M ($58K) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.